Alexandra Savinkina

1.4k total citations
34 papers, 842 citations indexed

About

Alexandra Savinkina is a scholar working on Epidemiology, Public Health, Environmental and Occupational Health and Management of Technology and Innovation. According to data from OpenAlex, Alexandra Savinkina has authored 34 papers receiving a total of 842 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Epidemiology, 13 papers in Public Health, Environmental and Occupational Health and 8 papers in Management of Technology and Innovation. Recurrent topics in Alexandra Savinkina's work include Opioid Use Disorder Treatment (11 papers), Blood donation and transfusion practices (8 papers) and Blood transfusion and management (6 papers). Alexandra Savinkina is often cited by papers focused on Opioid Use Disorder Treatment (11 papers), Blood donation and transfusion practices (8 papers) and Blood transfusion and management (6 papers). Alexandra Savinkina collaborates with scholars based in United States, Democratic Republic of the Congo and United Kingdom. Alexandra Savinkina's co-authors include Sridhar V. Basavaraju, Mathew R. P. Sapiano, Kathryn A. Haass, James J. Berger, Richard A. Henry, Matthew J. Kuehnert, Misha L. Baker, Benjamin P. Linas, Katherine Ellingson and Jefferson M. Jones and has published in prestigious journals such as Annals of Internal Medicine, Clinical Infectious Diseases and Addiction.

In The Last Decade

Alexandra Savinkina

33 papers receiving 825 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alexandra Savinkina United States 16 305 264 243 235 131 34 842
Dhuly Chowdhury United States 17 222 0.7× 226 0.9× 136 0.6× 179 0.8× 91 0.7× 38 838
Kathryn A. Haass United States 10 345 1.1× 85 0.3× 276 1.1× 44 0.2× 151 1.2× 15 586
Osaro Erhabor Nigeria 17 65 0.2× 122 0.5× 147 0.6× 310 1.3× 178 1.4× 114 899
Marinus van Hulst Netherlands 14 84 0.3× 33 0.1× 132 0.5× 170 0.7× 49 0.4× 59 666
Teddy Charles Adias Nigeria 10 41 0.1× 57 0.2× 95 0.4× 68 0.3× 126 1.0× 47 366
OUJ Umeora Nigeria 17 20 0.1× 184 0.7× 28 0.1× 194 0.8× 18 0.1× 82 889
Henry Ddungu Uganda 14 18 0.1× 210 0.8× 22 0.1× 53 0.2× 39 0.3× 34 490
Rune Philemon Tanzania 13 27 0.1× 103 0.4× 55 0.2× 64 0.3× 21 0.2× 51 485
Robin Ducharme Canada 12 24 0.1× 18 0.1× 20 0.1× 89 0.4× 17 0.1× 34 376
Godfrey Mugyenyi Uganda 15 12 0.0× 77 0.3× 11 0.0× 65 0.3× 40 0.3× 54 454

Countries citing papers authored by Alexandra Savinkina

Since Specialization
Citations

This map shows the geographic impact of Alexandra Savinkina's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alexandra Savinkina with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alexandra Savinkina more than expected).

Fields of papers citing papers by Alexandra Savinkina

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alexandra Savinkina. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alexandra Savinkina. The network helps show where Alexandra Savinkina may publish in the future.

Co-authorship network of co-authors of Alexandra Savinkina

This figure shows the co-authorship network connecting the top 25 collaborators of Alexandra Savinkina. A scholar is included among the top collaborators of Alexandra Savinkina based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alexandra Savinkina. Alexandra Savinkina is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Savinkina, Alexandra, Jason Kindrachuk, Isaac I. Bogoch, et al.. (2024). Modelling vaccination approaches for mpox containment and mitigation in the Democratic Republic of the Congo. The Lancet Global Health. 12(12). e1936–e1944. 7 indexed citations
2.
Savinkina, Alexandra, et al.. (2024). Estimated Deaths Averted in Adults by COVID-19 Vaccination in Select Latin American and Caribbean Countries. Open Forum Infectious Diseases. 11(10). ofae528–ofae528. 3 indexed citations
3.
Calcaterra, Susan L., Alexandra Savinkina, Laura R. Marks, et al.. (2023). Estimated Clinical Outcomes and Cost-effectiveness Associated With Provision of Addiction Treatment in US Primary Care Clinics. JAMA Network Open. 6(4). e237888–e237888. 7 indexed citations
4.
Savinkina, Alexandra, et al.. (2023). Mortality, incarceration and cost implications of fentanyl felonization laws: A modeling study. International Journal of Drug Policy. 121. 104175–104175. 2 indexed citations
5.
Chitwood, Melanie H., et al.. (2023). Estimated Testing, Tracing, and Vaccination Targets for Containment of the US Mpox Outbreak. JAMA Network Open. 6(1). e2250984–e2250984. 8 indexed citations
6.
Savinkina, Alexandra, et al.. (2023). Planning for Mpox on a College Campus: A Model-Based Decision-Support Tool. Annals of Internal Medicine. 176(3). 340–347. 6 indexed citations
7.
Savinkina, Alexandra, et al.. (2023). Short-term forecast of U.S. COVID mortality using excess deaths and vector autoregression. Model Assisted Statistics and Applications. 18(1). 13–31. 2 indexed citations
8.
Adams, Joëlla W., Alexandra Savinkina, Aaron D. Fox, et al.. (2022). Modeling the cost‐effectiveness and impact on fatal overdose and initiation of buprenorphine–naloxone treatment at syringe service programs. Addiction. 117(10). 2635–2648. 6 indexed citations
9.
Savinkina, Alexandra, Alyssa Bilinski, Meagan C. Fitzpatrick, et al.. (2022). Estimating deaths averted and cost per life saved by scaling up mRNA COVID-19 vaccination in low-income and lower-middle-income countries in the COVID-19 Omicron variant era: a modelling study. BMJ Open. 12(9). e061752–e061752. 24 indexed citations
10.
Savinkina, Alexandra, A. David Paltiel, Joseph S. Ross, & Gregg Gonsalves. (2022). Population-Level Strategies for Nirmatrelvir/Ritonavir Prescribing—A Cost-effectiveness Analysis. Open Forum Infectious Diseases. 9(12). ofac637–ofac637. 12 indexed citations
11.
12.
Adams, Joëlla W., Alexandra Savinkina, Simeon D. Kimmel, et al.. (2021). 58. Cost-Effectiveness of Emerging Antibiotic Strategies for the Treatment of Drug-Use Associated Infective Endocarditis. Open Forum Infectious Diseases. 8(Supplement_1). S40–S40.
13.
Sapiano, Mathew R. P., Jefferson M. Jones, Alexandra Savinkina, et al.. (2020). Supplemental findings of the 2017 National Blood Collection and Utilization Survey. Transfusion. 60(S2). S17–S37. 39 indexed citations
14.
Savinkina, Alexandra, Kathryn A. Haass, Mathew R. P. Sapiano, et al.. (2020). Transfusion‐associated adverse events and implementation of blood safety measures ‐ findings from the 2017 National Blood Collection and Utilization Survey. Transfusion. 60(S2). S10–S16. 23 indexed citations
15.
Jones, Jefferson M., Mathew R. P. Sapiano, Alexandra Savinkina, et al.. (2020). Slowing decline in blood collection and transfusion in the United States – 2017. Transfusion. 60(S2). S1–S9. 82 indexed citations
16.
Barocas, Joshua A., Alexandra Savinkina, & Benjamin P. Linas. (2020). Near-Term Outcomes Associated with COVID-19 in the United States Among Persons Experiencing Homelessness: A Modelling Study. SSRN Electronic Journal. 1 indexed citations
17.
Linas, Benjamin P., Alexandra Savinkina, Carolina Barbosa, et al.. (2020). A clash of epidemics: Impact of the COVID-19 pandemic response on opioid overdose. Journal of Substance Abuse Treatment. 120. 108158–108158. 78 indexed citations
18.
Savinkina, Alexandra, et al.. (2019). Predictive modeling for pituitary adenomas: single center experience in 501 consecutive patients. Pituitary. 22(5). 520–531. 30 indexed citations
19.
Edens, Chris, Kathryn A. Haass, Melissa Cumming, et al.. (2018). Evaluation of the National Healthcare Safety Network Hemovigilance Module for transfusion‐related adverse reactions in the United States. Transfusion. 59(2). 524–533. 16 indexed citations
20.
Richards, Morgan K., Adam B. Goldin, Alexandra Savinkina, et al.. (2016). The association between nephroblastoma-specific outcomes and high versus low volume treatment centers. Journal of Pediatric Surgery. 52(1). 104–108. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dhuly Chowdhury Breakdown of academic impact, for papers by Kathryn A. Haass Breakdown of academic impact, for papers by Osaro Erhabor Breakdown of academic impact, for papers by Marinus van Hulst Breakdown of academic impact, for papers by Teddy Charles Adias Breakdown of academic impact, for papers by OUJ Umeora Breakdown of academic impact, for papers by Henry Ddungu Breakdown of academic impact, for papers by Rune Philemon Breakdown of academic impact, for papers by Robin Ducharme Breakdown of academic impact, for papers by Godfrey Mugyenyi
Rankless by CCL
2026